BioSpace News Archive

Business

Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, provided a corporate update, and reported financial results for the first quarter ended March 31, 2024.

May 9, 2024
·
10 min read
Business

Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, reported financial results for the quarter ended March 31, 2024.

May 9, 2024
·
10 min read
Business

Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, reported financial results for the first quarter ended March 31, 2024 and provided a corporate update.

May 9, 2024
·
12 min read
Business

Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights

Nkarta, Inc., a clinical-stage biopharmaceutical company developing engineered natural killer cell therapies, reported financial results for the first quarter ended March 31, 2024.

May 9, 2024
·
8 min read
Business

Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results

Organogenesis Holdings Inc., a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, reported financial results for the first quarter ended March 31st, 2024.

May 9, 2024
·
15 min read
Business

HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress

HilleVax, Inc. reported financial results for the quarter ended March 31, 2024, highlighted recent progress and outlined key upcoming milestones for HIL-214, the company’s investigational virus-like particle based vaccine for the prevention of moderate-to-severe norovirus-related acute gastroenteritis.

May 9, 2024
·
5 min read
Business

BioLife Solutions Reports First Quarter 2024 Financial Results

BioLife Solutions, Inc. announced financial results for the three months ended March 31, 2024 and affirmed its revenue guidance for 2024.

May 9, 2024
·
17 min read
Business

Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights

Tyra Biosciences, Inc. reported financial results for the quarter ended March 31, 2024, and highlighted recent corporate progress.

May 9, 2024
·
11 min read
Business

Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights

Avidity Biosciences, Inc. reported financial results for the first quarter ended March 31, 2024, and highlighted recent corporate progress.

May 9, 2024
·
10 min read
Business

Arcellx Provides First Quarter 2024 Financial Results

Arcellx, Inc., a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, reported business highlights and financial results for the first quarter ended March 31, 2024.

May 9, 2024
·
5 min read